UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; ... Begent, RHJ; + view all (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. In: BRITISH JOURNAL OF CANCER. (pp. S8 - S8). NATURE PUBLISHING GROUP

Full text not available from this repository.
Type: Proceedings paper
Title: A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P
Event: British Cancer Research Meeting 2004
Location: Manchester, ENGLAND
Dates: 2004-06-27 - 2004-06-30
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
URI: http://discovery.ucl.ac.uk/id/eprint/162512
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item